Clustering data with hclust algorithm for Maternal Hypoxemia and oxidative stress in the fetus, newborn, and adult. exercise training for peripheral artery disease (Study ST000872)
Reversed phase POSITIVE ION MODE (Analysis AN001405)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OG | ME225498 | 1.45 | 0.18 | 0.07 | 0.09 | 0.11 | 0.40 | 0.18 | 0.86 | 0.10 | 0.06 | 0.07 | 0.05 | 0.04 | 6.52 | 9.40 |
| AG | ME225500 | 1.14 | 0.82 | 0.19 | 0.21 | 0.19 | 1.84 | 0.47 | 0.21 | 0.40 | 0.53 | 0.63 | 0.52 | 0.52 | 4.63 | 5.21 |
| LG | ME225499 | 1.47 | 0.73 | 0.11 | 0.13 | 0.11 | 1.94 | 0.39 | 0.44 | 0.38 | 0.07 | 0.09 | 0.07 | 0.28 | 6.05 | 6.45 |
| aLEA | ME225491 | 0.73 | 0.81 | 1.44 | 1.76 | 0.65 | 0.72 | 3.24 | 0.89 | 0.94 | 0.08 | 0.11 | 0.21 | 0.28 | 1.26 | 4.74 |
| NA-Gly | ME225497 | 0.86 | 0.72 | 0.65 | 1.10 | 2.22 | 0.89 | 2.75 | 1.16 | 1.26 | 0.65 | 1.17 | 0.70 | 0.62 | 1.17 | 0.96 |
| NO-Gly | ME225496 | 0.65 | 0.93 | 1.08 | 1.59 | 1.57 | 1.10 | 3.42 | 1.77 | 1.70 | 0.34 | 0.31 | 0.44 | 0.45 | 0.87 | 0.71 |
| DGLEA | ME225492 | 0.97 | 1.27 | 0.45 | 1.19 | 1.95 | 1.87 | 0.92 | 0.87 | 2.12 | 0.22 | 0.30 | 0.39 | 0.41 | 1.21 | 1.16 |
| LEA | ME225490 | 1.01 | 1.16 | 0.68 | 1.19 | 1.67 | 1.64 | 1.89 | 1.23 | 1.56 | 0.15 | 0.20 | 0.25 | 0.25 | 1.77 | 2.40 |
| DHEA | ME225495 | 0.72 | 1.08 | 0.71 | 0.94 | 0.75 | 0.89 | 0.95 | 0.75 | 0.95 | 0.73 | 0.78 | 1.33 | 1.16 | 1.10 | 2.90 |
| DEA | ME225494 | 0.94 | 0.82 | 0.43 | 0.73 | 1.15 | 1.45 | 0.83 | 0.85 | 1.04 | 0.98 | 1.04 | 0.90 | 0.59 | 2.47 | 1.30 |
| PEA | ME225487 | 1.02 | 0.90 | 1.28 | 0.88 | 0.81 | 1.22 | 1.03 | 1.17 | 0.84 | 0.98 | 1.41 | 0.93 | 0.91 | 1.02 | 0.89 |
| SEA | ME225488 | 1.05 | 0.97 | 1.51 | 1.14 | 0.84 | 1.33 | 0.98 | 0.91 | 0.93 | 0.74 | 1.15 | 0.76 | 0.84 | 1.27 | 1.08 |
| AEA | ME225493 | 0.86 | 1.03 | 0.76 | 1.03 | 1.30 | 1.80 | 1.71 | 1.49 | 1.45 | 0.60 | 0.53 | 0.81 | 0.75 | 0.88 | 1.01 |
| OEA | ME225489 | 0.76 | 0.83 | 0.86 | 1.54 | 0.88 | 1.23 | 1.63 | 1.20 | 1.15 | 0.47 | 0.54 | 0.92 | 0.86 | 1.04 | 2.09 |
Factors:
| F1 | Life stage:Adult | Pregnancy status:Non-pregnant | Treatment group:Hypoxic | Sample origin:Arterial |
| F2 | Life stage:Adult | Pregnancy status:Non-pregnant | Treatment group:Hypoxic | Sample origin:Venous |
| F3 | Life stage:Adult | Pregnancy status:Non-pregnant | Treatment group:Normoxic | Sample origin:Arterial |
| F4 | Life stage:Adult | Pregnancy status:Non-pregnant | Treatment group:Normoxic | Sample origin:Venous |
| F5 | Life stage:Adult | Pregnancy status:Pregnant | Treatment group:Hypoxic | Sample origin:Arterial |
| F6 | Life stage:Adult | Pregnancy status:Pregnant | Treatment group:Hypoxic | Sample origin:Venous |
| F7 | Life stage:Adult | Pregnancy status:Pregnant | Treatment group:Normoxic | Sample origin:Venous |
| F8 | Life stage:Adult | Pregnancy status:Unknown | Treatment group:Hypoxic | Sample origin:Arterial |
| F9 | Life stage:Adult | Pregnancy status:Unknown | Treatment group:Hypoxic | Sample origin:Venous |
| F10 | Life stage:Fetus | Pregnancy status:- | Treatment group:Hypoxic | Sample origin:Arterial |
| F11 | Life stage:Fetus | Pregnancy status:- | Treatment group:Hypoxic | Sample origin:Venous |
| F12 | Life stage:Fetus | Pregnancy status:- | Treatment group:Normoxic | Sample origin:Arterial |
| F13 | Life stage:Fetus | Pregnancy status:- | Treatment group:Normoxic | Sample origin:Venous |
| F14 | Life stage:Newborn | Pregnancy status:- | Treatment group:Hypoxic | Sample origin:Venous |
| F15 | Life stage:Newborn | Pregnancy status:- | Treatment group:Normoxic | Sample origin:Venous |
